arrow
L

Laurent Beaugerie

Sorbonne Universite
H指数:85
被引数:4.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Long-term safety of ustekinumab in Crohn’s disease: Descriptive analysis from an observational post-authorisation safety study using I-CARE cohort data

乌司奴单抗在克罗恩病中的长期安全性:一项基于I-CARE队列数据的观察性上市后安全性研究的描述性分析

2025-10-250
OAAI
Faecalibacterium Diversity in the Gut Microbiome of Crohn's Disease Patients

克罗恩病患者肠道微生物组中的Faecalibacterium多样性

2025-04-190
OAAI
Risk of anti-TNF therapy on pregnancy, breastfeeding, live vaccines and related information in patients with inflammatory bowel disease: Real-world data from a nationwide study
2024-12-010
PRE
Dynamic Prediction of Advanced Colorectal Neoplasia in Inflammatory Bowel Disease
2024-08-010
OAAI
Tuberculosis and Immune Reconstitution Inflammatory Syndrome in Patients With Inflammatory Bowel Disease and Anti-TNFα Treatment: Insights From a French Multicenter Study and Systematic Literature Review With Emphasis on Paradoxical Anti-TNFα Resumption
2024-06-170
OAAI
The universal effects of low-dose interleukin-2 across 13 autoimmune diseases in a basket clinical trial
2024-04-0111
PRE
Lymphoma in Patients with Inflammatory Bowel Disease: A Multicentre Collaborative Study Between GETAID and LYSA
2023-10-180
PRE
Impact of HIV Infection on the Course of Inflammatory Bowel Disease and Drug Safety Profile: A Multicenter GETAID Study
2023-08-018
PRE
PERFUSE: a French non-interventional study of patients with inflammatory bowel disease receiving infliximab biosimilar SB2: a 12-month analysis

PERFUSE: 接受英夫利昔单抗生物仿制药SB2的炎症性肠病患者的法国非干预性研究: 12个月的分析

2023-03-156
OAAI
I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease
2023-03-0118
OAAI
Large-scale sequencing identifies multiple genes and rare variants associated with Crohn's disease susceptibility

大规模测序鉴定与克罗恩病易感性相关的多个基因和罕见变异

2022-08-2975
OA